Inventor · disambiguated record
Manoj Maniar
Also filed as: MANIAR MANOJ · MANIAR MANOJ L · MANIOR MANOJ
24 granted patents·7 pending applications·1,461 citations·filing 1990–2022
97Inventor score
Files withONCONOVA THERAPEUTICS INC7NOVA PHARM CORP5MANIAR MANOJ4ALCON LAB INC3MASSACHUSETTS INST TECHNOLOGY2
Top patents by PatentIndex Score
31 records- 0198US5227165ALiposphere delivery systems for local anestheticsNOVA PHARM CORP·Filed 1992·Granted Jul 13, 1993·176 cites·29 claims
- 0296US5512055AAnti-infective and anti-inflammatory releasing systems for medical devicesBLOOM LEONARD·Filed 1994·Granted Apr 30, 1996·566 cites·9 claims
- 0396US5482927AControlled released microparticulate delivery system for proteinsMASSACHUSETTS INST TECHNOLOGY·Filed 1994·Granted Jan 9, 1996·221 cites·18 claims
- 0496US5175235ABranched polyanhydridesNOVA PHARM CORP·Filed 1990·Granted Dec 29, 1992·82 cites·14 claims
- 0590US8476320B2Formulations for parenteral administration of amino-substituted (E)-2, 6-dialkoxystyryl 4-substituted benzylsulfonesMANIAR MANOJ·Filed 2008·Granted Jul 2, 2013·17 cites·12 claims
- 0689US5886030AUse of vitamin E tocopheryl derivatives in ophthalmic compositionsALCON LAB INC·Filed 1995·Granted Mar 23, 1999·91 cites·9 claims
- 0787US5874469AFluoroalkyl hydrocarbons for administering water insoluble or unstable drugsALCON LAB INC·Filed 1996·Granted Feb 23, 1999·82 cites·16 claims
- 0886US10576047B2Formulations for the treatment of painGRUENENTHAL GMBH·Filed 2018·Granted Mar 3, 2020·3 cites·13 claims
- 0986US8063109B2Formulations for parenteral administration of (e)-2, 6-dialkoxystyryl 4-substituted benzylsulfonesBELL STANLEY C·Filed 2005·Granted Nov 22, 2011·12 cites·20 claims
- 1081US11382877B2Formulation of (E)-2,4,6-trimethoxystyryl-3-[(carboxymethyl)amino]-4-methoxybenzylsulphone with enhanced stability and bioavailabilityONCONOVA THERAPEUTICS INC·Filed 2018·Granted Jul 12, 2022·1 cites·14 claims
- 1179US10098862B1Formulations with enhanced stability and bioavailability for administration of (E)-2,6-dialkoxystyryl 4-substituted benzylsulfonesONCONOVA THERAPEUTICS INC·Filed 2017·Granted Oct 16, 2018·2 cites·33 claims
- 1276US8889736B2Formulations for the treatment of painMANIAR MANOJ·Filed 2011·Granted Nov 18, 2014·2 cites·20 claims
- 1374US9044427B2Compositions and methods for prevention and treatment of woundsKUMAR RAMESH·Filed 2011·Granted Jun 2, 2015·4 cites·9 claims
- 1473US5919835ABiodegradable polymer blends for drug deliveryMASSACHUSETTS INST TECHNOLOGY·Filed 1992·Granted Jul 6, 1999·46 cites·12 claims
- 1569US9060967B2Stable aqueous formulation of (E)-4-carboxystyryl-4-chlorobenzyl sulfoneMANIAR MANOJ·Filed 2011·Granted Jun 23, 2015·1 cites·14 claims
- 1663US2015250745A1Formulation for the treatment of painACORDA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 1762US5240963ABranched polyanhydridesNOVA PHARM CORP·Filed 1992·Granted Aug 31, 1993·50 cites·7 claims
- 1860US10576050B2Methods and compositions for treatment of cancerONCONOVA THERAPEUTICS INC·Filed 2013·Granted Mar 3, 2020·1 cites·10 claims
- 1960US5705510AUse of cabergoline and related ergoline derivatives for controlling intraocular pressureALCON LAB INC·Filed 1995·Granted Jan 6, 1998·25 cites·9 claims
- 2058US5179189AFatty acid terminated polyanhydridesNOVA PHARM CORP·Filed 1991·Granted Jan 12, 1993·41 cites·13 claims
- 2157US12156856B2Formulation of (e)-2,4,6-trimethoxystyryl-3-[(carboxymethyl)amino]-4-methoxybenzylsulphone with enhanced stability and bioavailabilityTRAWS PHARMA INC·Filed 2022·Granted Dec 3, 2024·0 cites·5 claims
- 2257US11583552B2Pharmaceutical formulation of arsenic trioxideMANIAR MANOJ·Filed 2021·Granted Feb 21, 2023·0 cites·14 claims
- 2357US2006100272A1Formulations for the treatment of painSTANFORD RES INST INT·Filed 2005·Application pending·0 cites
- 2455US2006018951A1pH-responsive film for intravaginal delivery of a beneficial agentSTANFORD RES INST INT·Filed 2004·Application pending·0 cites
- 2555US2009247624A1Formulations of radioprotective alpha beta unsaturated aryl sulfonesONCONOVA THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 2655US2011028504A1Formulation of radioprotective alpha beta unsaturated aryl sulfonesONCONOVA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 2748US5317079AFatty acid terminated polyanhydrideNOVA PHARM CORP·Filed 1992·Granted May 31, 1994·27 cites·11 claims
- 2847US9713597B2Stable aqueous formulation of (E)-4-carboxystyryl-4-chlorobenzyl sulfoneONCONOVA THERAPEUTICS INC·Filed 2015·Granted Jul 25, 2017·0 cites·9 claims
- 2944US2022002293A18-cyclopentyl-7-oxo-2-(4-piperazin-1-yl-phenylamino)-7, 8-dihydro-pyrido [2,3-d]pyrimidine-6-carbonitrile and uses thereof in treating proliferative disordersONCONOVA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3043US5846525AProtected biopolymers for oral administration and methods of using sameTREGA BIOSCIENCES INC·Filed 1995·Granted Dec 8, 1998·11 cites·14 claims
- 3142US2015238448A1Formulation of radioprotective alpha, beta unsaturated aryl sulfonesBELL STANELY C·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →